In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 3, 1998, Pages 333-339

  Pradines, B ^a   Tall, A ^b   Parzy, D ^a   Spiegel, A ^b   Fusai, T ^a   Hienne, R ^a   Trape, J F ^c   Doury, J C ^a  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; CHLOROQUINE; PYRONARIDINE; QUININE;

ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMODIUM FALCIPARUM; SENEGAL; STRAIN DIFFERENCE;

AFRICA; AMODIAQUINE; ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; HUMANS; NAPHTHYRIDINES; PLASMODIUM FALCIPARUM; QUININE;

EID: 0031692969     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.3.333     Document Type: Article

References (45)

1. Wernsdorfer, W. H. (1991). The development and spread of drug-resistant malaria. Parasitology Today 7, 297-303.
2. Barnes, A. J., Ong, E. L., Dunbar, E. M., Mandal, B. K. & Wilkins, E. G. L. (1991). Failure of chloroquine and proguanil prophylaxis in travellers to Kenya. Lancet 338, 1338-9.
3. Ringwald, P., Bartczak, S., Le Bras, J., Bricaire, F., Matheron, S., Bauchet, J. et al. (1990). Failure of anti-malarial prophylaxis with mefloquine in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 348-9.
4. Gay, F., Binet, M. H., Bustos, M. D. G., Rouveix, B., Danis, M., Roy, C. et al. (1990). Mefloquine failure in child contracting falciparum malaria in West Africa. Lancet 335, 120-1.
5. Basco, L. K., Le Bras, J., Gillotin, C., Ringwald, P., Rabenjarson, E., Gimenez, F. et al. (1991). Type RI resistance to halofantrine in West Africa. Tropical Medicine and Parasitology 42, 413-4.
6. Jelinek, T., Schelbert, P., Loscher, T. & Eichenlaub, D. (1995). Quinine resistant falciparum malaria acquired in east Africa. Tropical Medicine and Parasitology 46, 38-40.
7. Molinier, S., Imbert, P., Verrot, D., Morillon, M., Parzy, D. & Touze, J. E. (1994). Plasmodium falciparum malaria: type R1 quinine resistance in East Africa. Presse Medicale 23, 1494.
8. Zeng, X. Y., Xia, Y., Gao, F. H. & Chen, C. (1979). Synthesis of 7351, a new antimalarial drug. Acta Pharmaceutica Sinica 14, 736-7.
9. Zeng, X. Y., Chen, C., Gao, F. H., Zhu, P. E. & Quo, H. Z. (1982). Synthesis of new antimalarial drug pyronaridine and its analogues. Acta Pharmaceutica Sinica 17, 118-25.
10. Shao, B. R. (1990). A review of antimalarial drug pyronaridine. Chinese Medical Journal 103, 428-34.
11. Ringwald, P., Bickii, J. & Basco, L. (1996). Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347, 24-8.
12. Peters, W. & Robinson, B. L. (1992). The chemotherapy of rodent malaria. XLVII. Studies on pyronaridine and other Mannich base antimalarials. Annals of Tropical Medicine and Parasitology 86, 455-65.
13. Kotecka, B. M., Barlin, G. B., Edstein, M. D. & Rieckmann, K. H. (1997). New quinoline di-mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine or pyronaridine. Antimicrobial Agents and Chemotherapy 41, 1369-74.
14. Childs, G. E., Hausler, B., Milhous, W., Chen, C., Wimonwattrawatee, T., Pooyindee, N. et al. (1988). In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 38, 24-9.
15. Elueze, E. I., Croft, S. L. & Warhurst, D. C. (1996). Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro. Journal of Antimicrobial Chemotherapy 37, 511-8.
16. Muller, O., van Hensbroek, M. B., Jaffar, S., Drakeley, C., Okorie, C., Joof, D. et al. (1996). A randomized trial of chloroquine, amodiaquine, and pyrimethamine/sulphadoxine in Gambian children with uncomplicated malaria. Tropical Medicine and International Health 1, 124-32.
17. Neftel, K. A., Woodtly, W., Schmid, M., Frick, P. G. & Fehr, J. (1986). Amodiaquine induced agranulocytis and liver damage. British Medical Journal 292, 721-3.
18. World Health Organization, Division of Tropical Diseases. (1990). Severe and complicated malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, Suppl. 2, 1 -65.
19. Warsame, M., Wernsdorfer, W. H., Payne, D. & Bjorkman, A. (1991). Positive relationship between response of Plasmodium falciparum to chloroquine and pyronaridine. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 570-1.
20. Basco, L. K. & Le Bras, J. (1992). In vitro activity of pyronaridine against African strains of Plasmodium falciparum. Annals of Tropical Medicine and Parasitology 86, 447-54.
21. Rogier, C. & Trape, J. F. (1996). Development of premunition in malaria holo-and mesoendemic areas, in Dielmo and Ndiop, Senegal: preliminary results, 1990-1994. Médecine Tropicale 55, Suppl., 71-6.
22. Trape, J. F., Rogier, C., Konate, L., Diagne, N., Bouganali, H., Canque, B. et al. (1994). The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. American Journal of Tropical Medicine and Hygiene 51, 123-37.
23. Pradines, B., Rogier, C., Fusai, T., Tall, A., Trape, J. F. & Doury, J. C. (1996). In vitro susceptibilty of 85 Plasmodium falciparum isolates in the Fatick region of Senegal. Médecine Tropicale 56, 141-5.
24. Alin, M. H., Bjorkman, A. & Ashton, M. (1990). In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 635-7.
25. Schildbach, S., Wernsdorfer, W. H., Suebsaeng, L. & Rooney, W. (1990). In vitro sensitivity of multiresistant Plasmodium falciparum to new candidate antimalarial drugs in western Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 21, 29-38.
26. Benito, A., Roche, J., Molina, R., Amela, C. & Alvar, J. (1995). In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in Equatorial Guinea. American Journal of Tropical Medicine and Hygiene 53, 526-31.
27. Brasseur, P., Agnamey, P., Ekobo, A. S., Samba, G., Favennec, L. & Kouamouo, J. (1995). Sensitivity of Plasmodium falciparum to amodiaquine and chloroquine in central Africa: a comparative study in vivo and in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 528-30.
28. White, N. J. (1992). Antimalarial drug resistance: the pace quickens. Journal of Antimicrobial Chemotherapy 30, 571-35.
29. Yayon, A., Cabantchik, Z. I. & Ginsburg, H. (1985). Susceptibility of human malaria parasites to chloroquine is pH dependent. Proceedings of the National Academy of Sciences of the USA 82, 2784-8.
30. Krogstad, D. J., Schlesinger, P. H. & Gluzman, I. Y. (1985). Antimalarials increase vesicle pH in Plasmodium falciparum. Journal of Cell Biology 101, 2302-9.
31. Slater, A. F. G. & Cerami, A. (1992). Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355, 167-9.
32. Krogstad, D. J., Gluzman, I. Y., Kyle, D. E., Oduola, A. M. J., Martin, S. K., Milhous, W. K. et al. (1987). Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238, 1283-5.
33. Cowman, A. F., Karcz, S., Galatis, D. & Culvenor, J. G. (1991). A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. Journal of Cell Biology 113, 1033-45.
34. Walliker, D. (1994). The role of molecular genetics in field studies on malaria parasites. International Journal for Parasitology 24, 799-808.
35. Wellems, T. E., Walker-Jonah, A. & Panton, L. J. (1991). Genetic mapping of the chloroquine resistance locus on Plasmodium falciparum chromosome 7. Proceedings of the National Academy of Sciences of the USA 88, 3382-6.
36. Wu, L. J., Rabbege, J. R., Nagasawa, H., Jacobs, G. & Aikawa, M. (1988). Morphological effects of pyronaridine on malaria parasites. American Journal of Tropical Medicine and Hygiene 38, 30-6.
37. Bray, P. G., Hawley, S. R. & Ward, S. A. (1996). 4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake. Molecular Pharmacology 50 1551-8.
38. Basco, L. K., Le Bras, J., Rhoades, Z. & Wilson, C. M. (1995). Analysis of pfmdr 1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. Molecular and Biochemical Parasitology 74, 157-66.
39. Duraisingh, M. T., Drakeley, C. J., Muller, O., Bailey, R., Snounou, G., Targett, G. A. T. et al. (1997). Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 114, 205-11.
40. Peters, W. & Robinson, B. L. (1997). The chemotherapy of rodent malaria. LV. Interactions between pyronaridine and artemisinin. Annals of Tropical Medicine and Parasitology 91, 141-5.
41. Pradines, B., Rogier, C., Fusai, T., Tall, A., Trape, J. F. & Doury, J. C. (1998). In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs. American Journal of Tropical Medicine and Hygiene 58, 354-7.
42. Chang, C., Lin-Hua, T. & Jantanavivat, C. (1992). Studies on a new antimalarial compound: pyronaridine. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 7-10.
43. Winstanley, P. (1996). Pyronaridine: a promising drug for Africa? Lancet 347, 2-3.
44. Olliaro, P., Nevill, C., Le Bras, J., Ringwald, P., Mussano, P., Garner, P. et al. (1996). Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348, 1196-201.
45. Naisbitt, D. J., Ruscoe, J. E., Williams, D., O'Neill, P. M., Pirmohamed, M. & Park, B. K. (1997). Disposition of amodiaquine and related antimalarial agents in human neutrophils: implications for drug design. Journal of Pharmacology and Experimental Therapeutics 280, 884-93.